2012-11-30T16:00:51-06:00 2012-03-31 ERNST & YOUNG US LLP 1901 SIXTH AVENUE NORTH SUITE 1200 BIRMINGHAM AL 35203 990 2011-04-01 260850638 Susan G Komen for the Cure Advocacy Alliance % Mark Nadolny SUSA 9728551600 5005 LBJ FREEWAY DALLAS TX 752446125 MARK NADOLNY 2012-11-29 2052541608 2011 2016-02-24 21:20:13Z Ambassador Nancy G Brinker 5005 LBJ Freeway Suite 250 Dallas TX 75244 2277717 false X WWW.KOMENADVOCACY.ORG X 2007 TX Our mission is to translate the promise to save lives and end breast cancer forever into action at all levels of government to discover and deliver the cures. 14 14 0 550 0 0 2132014 2277717 0 0 -13500 0 0 0 2118514 2277717 0 0 0 0 938257 807872 39372 0 10607 2433295 1875013 3410924 2682885 -1292410 -405168 366712 335674 4030698 4404828 -3663986 -4069154 X SEE SCHEDULE O. false false 1005526 0 0 State issues education and advocacy. See Schedule O for more detail. 899297 0 0 Federal issues education and advocacy. See schedule O for more DETAIL. 486805 0 0 Grassroots outreach and education. See schedule O for more detail. 0 0 0 2391628 false true false true false false false false false false false false false false true false true false false false false false false false false false false false true false false false false false false false false false false false false false false false false false true 14 0 true 0 false false false false true true false X 14 14 false false false false true true true true true false false true true true true true true true false false AL AK AZ AR CA CO CT DC FL GA HI IL KS KY ME MD MA MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X Mark Nadolny 9728551600 5005 LBJ FREEWAY SUITE 250 DALLAS TX 752446125 KAREN L WEBSTER 1.0 X X 0 0 0 JANE ABRAHAM 1.0 X 0 0 0 GRACE BENDER 1.0 X 0 0 0 EVE BENTON 1.0 X 0 0 0 AMBASSADOR NANCY G BRINKER 5.0 X X 0 0 0 DEBBIE DINGELL 1.0 X 0 0 0 LILA HERTZ 1.0 X 0 0 0 ALEXINE CLEMENT JACKSON 1.0 X 0 0 0 TINA LEWIS 1.0 X 0 0 0 JOYCE MAZERO 1.0 X 0 0 0 GINGER PAPE 1.0 X 0 0 0 CAROL PENFOLD-PATTERSON 1.0 X 0 0 0 ELYSIA HOLT RAGUSA 1.0 X 0 0 0 JOHN D RAFFAELLI 1.0 X 0 0 0 STEPHANIE SIEGEL 1.0 X 0 0 0 CHERYL JERNIGAN 1.0 X 0 0 0 JONATHAN BLUM 1.0 X 0 0 0 MARK NADOLNY 1.0 X 0 0 0 LESLEY LURIE 1.0 X 0 0 0 KAREN HANDEL 55.0 X 166569 0 1711 ELIZABETH THOMPSON 1.0 X 0 0 0 166569 0 1711 1 false true false FOLEY HOAG LLP SEAPORT WORLD TRADE CENTER - WEST BOSTON MA 022102600 GOVT RELS./PUB AFFS. 247000 EVANS CAPITOL GROUP 450 MASSACHUSETTS AVE WASHINGTON DC 200063939 GOVT RELS./PUB AFFS. 150016 DAVID K REHR 2750 N QUEBEC STREET ARLINGTON VA 22207 CONSULTING 105260 R STRATEGY GROUP 812 HURON ROAD E SUITE 890 CLEVELAND OH 44115 CONSULTING 126871 4 2277717 2277717 0 0 0 0 0 0 0 0 0 2277717 0 0 0 0 0 0 0 168280 143038 25242 0 510388 431293 79095 9551 8083 1468 70026 59254 10772 49627 41997 7630 0 14361 14361 0 486195 486195 0 0 0 800 680 120 26611 29507 -4965 2069 0 0 0 181891 159038 22853 0 110692 109899 793 70247 59710 10537 0 0 0 CONSULTING AND PROFESSIONAL 144998 141022 3976 CONTRACT LABOR 18358 17314 1044 Shared service fees 800000 680000 120000 0 Bank fees 9004 0 4442 4562 11856 10237 1619 2682885 2391628 280650 10607 X 0 0 13022 72181 353690 233493 0 0 0 0 0 0 0 0 0 0 0 30000 0 0 0 0 0 0 0 0 0 0 0 366712 335674 168795 122928 0 0 0 0 0 0 0 0 0 0 3861903 4281900 0 0 0 0 4030698 4404828 X -3663986 -4069154 0 0 0 0 -3663986 -4069154 366712 335674 -405168 X false true true X false RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true false false Were all dues substantially non-deductible by members Schedule C, Part III-A, Line 1 Per the IRS instructions, entities that are not membership organizations should answer yes to Part III-A, Line 1. Since this organization does not assess "membership" dues, the taxpayer is not a dues paying membership organization. If dues were paid, they would be non-deductible. 0 0 FIN 48 (ASC740) Financial Statement Disclosure Schedule D, Part X, Line 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS IN THE FINANCIAL STATEMENTS AT MARCH 31, 2012 OR MARCH 31, 2011. X X X X X false false false false false false false false false KAREN HANDEL 165501 0 450 0 618 0 0 0 1711 0 168280 0 0 0 Supplemental Compensation Information Form 990, Part VII and Schedule J-2 Form 990, Part V, Line 2A - Number of employees reported on Form W-3 reported as zero (-0-). The Organization currently has no employees and utilizes employees of The Susan G. Komen Breast Cancer Foundation, Inc. (The Foundation) through a shared services agreement with costs and expenses reimbursed by the Organization. All wages of Advocacy Alliance have been appropriately included in the Foundation's payroll related reporting and tax filings under EIN # 75-1835298. Although the employees that participate in the shared services are included as part of the Foundation's payroll tax filings, the salaries and related expenses are shown on the Advocacy Alliance Form 990, Part VII and Part IX, Lines 5 through 10. Schedule J, Part I, Line 7 The individuals listed on schedule J are employees of Susan G Komen for the Cure Breast Cancer Foundation and participate in that organization's bonus and incentive compensation plan. All employees are eligible to participate in the bonus incentive plan. There were no payments made in calendar year 2011. SUPPLEMENTAL INFORMATION Part III, LINE 1 ORGANIZATION'S MISSION The Susan G. Komen for the Cure Advocacy Alliance (KAA) is the non-profit, non-partisan advocacy organization that provides a voice for the 2.9 million breast cancer survivors and those who love them. As such, KAA works to educate and encourage lawmakers, candidates, and government leaders to support legislative, regulatory and other policies that will help end breast cancer forever. Part III, LINES 4A-4C State Issues: Education and Advocacy KAA developed and implemented various education and advocacy initiatives to encourage state elected and agency officials to support policies and legislation that further the overall mission to end breast cancer forever. KAA coordinated various grassroots campaigns to mobilize the KAA network of breast cancer advocates in support of those initiatives. These efforts helped to preserve over $107 million in state funding for safety net breast cancer screening programs that serve low income, uninsured and underinsured women. KAA was also involved in efforts to expand insurance coverage for orally-administered anti-cancer medications and expand access to Medicaid-funded treatment services under the Breast & Cervical Cancer Treatment Act. Federal Issues: Education and Advocacy Through education, outreach, advocacy initiatives and regulatory comment letters, KAA worked to encourage federal lawmakers, agency heads, and candidates to support and implement programs, legislation, and policies that advance our mission of ending breast cancer forever. Specifically, KAA, with the support of its network of breast cancer advocates, engaged in efforts to educate lawmakers about the importance of early detection and to encourage their support for funding for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and for continuing to invest in breast cancer research. These efforts helped to maintain $206 million for NBCCEDP in the FY12 budget and $30.698 billion for the NIH budget (an increase of 1%) and $5.081 billion for the NCI budget (an increase of 1%). KAA has also focused on advocating for policies that directly serve individuals with breast cancer, survivors, and those who may develop breast cancer in the future, such as providing access to and coverage for quality preventive programs as well as affordable and quality treatment for women and men facing breast cancer. Additionally, KAA focused its advocacy efforts on oral chemotherapy parity, drug shortages, FDA approval, and addressing health care disparities. KAA submitted ten regulatory comment letters to ensure that health care legislation is implemented in a manner that takes into account the needs of those impacted by breast cancer. The topics of these comment letters included setting up health insurance exchanges, addressing drug shortages, defining an essential benefits package, and recommendations for the Patient Centered Outcomes Research Institute (PCORI) research agenda. Grassroots Outreach and Education. KAA actively recruited advocates to further strengthen its grassroots advocacy network. KAA also implemented various programs to educate and engage advocates in breast cancer policy issues. Member Election Form 990, Part VI, Question 6, 7a & 7b Susan G. Komen for the Cure Advocacy Alliance's corporate documents provide for a sole Class A Voting Member and Class B Non-Voting Members. The sole Class A Voting Member is The Susan G. Komen Breast Cancer Foundation, Inc. Currently, there are no Class B Non-Voting Members. The Class A Voting Member may elect up to 15 members of the 31 maximum member Board of Directors, but in no event will the Board of Directors have more than one less Class A Director than non-Class A Directors. The Class A Voting Member may elect 4 members of the 9 member Executive Committee of the Board of Directors, with the remaining 5 members elected by the Board. The Class A Voting Member approves all Non-Class A directors elected to the Board and to the Executive Committee. The Board of Directors needs the affirmative vote of the Class A Voting Member for any amendment or restatement of the Certificate of Formation, adoption, material alteration, material amendment or repeal of the Bylaws, any merger, creation of or dissolution of any subsidiaries or other legally-related organizations, entry into any contracts with a value in excess of $500,000 in the aggregate, material modification of the Susan G. Komen for the Cure Advocacy Alliance's tax exempt status, sale of all or substantially all of the assets, conveyance of any real property, plan of conversion, plan of exchange, voluntary winding up or plan of distribution of the Susan G. Komen for the Cure Advocacy Alliance. Describe the Process used by Management &/or Governing Body to Review 990 Form 990, Part VI, Question 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVELS OF MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR PRESENTATION TO THE BOARD. The Board or the Executive Committee of the Board of Directors reviews and approves the Form 990 prior to being filed. Thereafter, each member of the Board of Directors receives an electronic copy of the Form 990 via email prior to the form being filed. Description of Process to Monitor Transactions for Conflicts of Interest Form 990, Part VI, Question 12c The organization produces an annual survey requiring all employees, board members, committee members and advisory boards to inform on conflicts. Any conflicts are then reviewed by management and the audit committee and appropriate measures are taken. In addition, those same people have the obligation to update the conflict of interest statements during the year. Offices & Positions for Which Process was Used, & Year Process was Begun Form 990, Part VI, Question 15a & 15b Beginning in 2007, the Board of Directors oversees compensation policies and practices. Responsibilities include oversight of the compensation of the top management official, the range of compensation levels for the Organization's employees, and incentive/bonus compensation programs. The Organization currently has no employees and utilizes employees of The Susan G. Komen Breast Cancer Foundation, Inc. through a shared services agreement with costs and expenses reimbursed by the Organization. As part of the shared services, the Susan G. Komen for the Cure Advocacy Alliance utilizes the assistance of The Susan G. Komen Breast Cancer Foundation, Inc. in determining appropriate and reasonable compensation levels. The Susan G. Komen Breast Cancer Foundation, Inc. maintains a formal compensation policy that governs pay practices. Periodically, all positions are reviewed against external market data, engaging independent experts to conduct the benchmarking process. Compensation is then based upon comparable market rates of pay with consideration for internal equity and the financial position of the Organization. For the Top Management Official, external benchmarking was conducted again this fiscal year to ensure market alignment. Salary increases, promotions or other forms of compensation are provided without regard to race, color, religion, gender, national origin, disability, veteran status or sexual orientation. Avail of Gov Docs, Conflict of Interest Policy, & Fin Stmts to Gen Public Form 990, Part VI, Question 19 The Organization's financial statements, conflict of interest policy and the 990 are publicly available on our website. The Articles of Incorporation are available from the Texas Secretary of State and other governing documents are made available as required by state law. Form 1023 is not online but available to the public upon request. Additionally, improper conduct concerns are filed on the Komen.org website.